Diabetic Angiopathies

They are associated with diabetes mellitus, particularly the metabolic milieu of hyperglycemia and insulin resistance. The supplied material also links diabetic vascular complications with excess free fatty acids and glycemic indices such as hyperglycemia and glucose variability.

The literature describes endothelial dysfunction as a central initiating event, with reduced nitric oxide bioavailability, increased vasoconstrictor activity, platelet hyperactivity, oxidative stress, and low-grade inflammation. Pathologic changes also include atherosclerosis, impaired microvascular endothelial function, basement membrane thickening, and microthrombosis.

Diabetes mellitus itself is a major risk factor for vascular disease. The supplied grounding also associates diabetic vascular complications with hyperglycemia, glucose variability, smoking, oxidative stress, and platelet activation.

The supplied grounding supports management at the level of diabetes care and vascular complication prevention rather than a specific disease-directed regimen. It mentions drug therapy and therapeutic strategies focused on vascular complications, but does not provide enough detail to name a specific standard treatment class for diabetic angiopathies.